ALCYONE THERAPEUTICS, INC. — TTAB Proceedings
ALCYONE THERAPEUTICS, INC. is a party to 3 TTAB proceedings.
Proceedings
- Proceeding 97063853 — Ex Parte Appeal, Terminated (filed 2023-12-11) as plaintiff
- Proceeding 97063862 — Ex Parte Appeal, Terminated (filed 2023-12-11) as plaintiff
- Proceeding 92083616 — Cancellations, Terminated (filed 2023-11-06) against Falcon Pharmaceuticals, Ltd. as plaintiff
Marks in These TTAB Matters
- FALCON — proceeding 97063853 (Plaintiff)
- FALCON-EDGE — proceeding 97063862 (Plaintiff)
- FALCON — proceeding 92083616 (Plaintiff)
- FALCON-EDGE — proceeding 92083616 (Plaintiff)
Recent Live Filings
- THECAFLEX DRX — Registered, filed 2019-02-09
Common TTAB Counterparties
- Falcon Pharmaceuticals, Ltd. — 1 proceedings
Recent TTAB Timeline
- 2024-08-15: 97063853 — TERMINATED
- 2024-08-15: 97063862 — TERMINATED
- 2024-03-26: 92083616 — TERMINATED involving Falcon Pharmaceuticals, Ltd.
- 2024-03-26: 92083616 — COMMR ORDER CANCELLING REG involving Falcon Pharmaceuticals, Ltd.
- 2024-03-21: 92083616 — REFUND ISSUED - TRADEMARK RULE 2.114(A)(2) involving Falcon Pharmaceuticals, Ltd.
- 2024-03-21: 92083616 — REFUND IN PROCESS - TRADEMARK RULE 2.114(A)(2) involving Falcon Pharmaceuticals, Ltd.
- 2024-02-07: 92083616 — BOARD'S DECISION: GRANTED involving Falcon Pharmaceuticals, Ltd.
- 2023-12-28: 92083616 — NOTICE OF DEFAULT involving Falcon Pharmaceuticals, Ltd.
- 2023-12-11: 97063862 — PENDING, INSTITUTED
- 2023-12-11: 97063853 — PENDING, INSTITUTED
- 2023-12-11: 97063853 — APPEAL ACKNOWLEDGED; CASE REMANDED
- 2023-12-11: 97063862 — APPEAL ACKNOWLEDGED; CASE REMANDED
- 2023-12-11: 97063862 — APPEAL TO BOARD
- 2023-12-11: 97063853 — APPEAL TO BOARD
- 2023-11-07: 92083616 — PENDING, INSTITUTED involving Falcon Pharmaceuticals, Ltd.
- 2023-11-07: 92083616 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Falcon Pharmaceuticals, Ltd.
- 2023-11-06: 92083616 — FILED AND FEE involving Falcon Pharmaceuticals, Ltd.